Blair William & CO Ocuphire Pharma, Inc. Transaction History
Blair William & CO
- $31.4 Billion
- Q1 2024
A detailed history of Blair William & CO transactions in Ocuphire Pharma, Inc. stock. As of the latest transaction made, Blair William & CO holds 33,267 shares of OCUP stock, worth $66,201. This represents 0.0% of its overall portfolio holdings.
Number of Shares
33,267
Previous 33,267
-0.0%
Holding current value
$66,201
Previous $100,000
34.0%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding OCUP
# of Institutions
49Shares Held
3.42MCall Options Held
3.6KPut Options Held
6.2K-
Vanguard Group Inc Valley Forge, PA992KShares$1.97 Million0.0% of portfolio
-
Rice Hall James & Associates, LLC292KShares$581,0500.04% of portfolio
-
Geode Capital Management, LLC Boston, MA234KShares$466,4520.0% of portfolio
-
Richmond Brothers, Inc. Jackson, MI227KShares$452,6470.87% of portfolio
-
Mai Capital Management224KShares$445,7000.0% of portfolio
About Ocuphire Pharma, Inc.
- Ticker OCUP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 20,579,800
- Market Cap $41M
- Description
- Ocuphire Pharma, Inc., a clinical-stage ophthalmic biopharmaceutical company, focuses on developing and commercializing therapies for the treatment of refractive and retinal eye disorders. Its lead product candidate is Nyxol eye drops, a once-daily preservative-free eye drop formulation of phentolamine mesylate, which is in Phase III clinical tr...